Consolidated Statements of Comprehensive Income |
12 Months Ended | |||
|---|---|---|---|---|
|
Mar. 31, 2016
USD ($)
$ / shares
|
Mar. 31, 2016
CNY (¥)
¥ / shares
|
Mar. 31, 2015
CNY (¥)
¥ / shares
|
Mar. 31, 2014
CNY (¥)
¥ / shares
|
|
| Consolidated Statements of Comprehensive Income | ||||
| Net revenues | $ 64,692,923 | ¥ 417,139,969 | ¥ 350,157,824 | ¥ 384,668,378 |
| Cost of revenues | 32,260,733 | 208,017,208 | 172,539,260 | 188,480,346 |
| Gross profit | 32,432,190 | 209,122,761 | 177,618,564 | 196,188,032 |
| Operating expenses: | ||||
| Research and development | 5,665,190 | 36,529,145 | 36,836,338 | 27,673,298 |
| Sales and marketing | 6,613,784 | 42,645,682 | 45,186,175 | 47,259,273 |
| General and administrative | 12,149,685 | 78,341,173 | 64,759,122 | 71,605,616 |
| Impairment of intangible assets | 0 | 310,153 | 12,009,457 | |
| Provision for (reversal of) doubtful accounts | (19,828) | (127,852) | 845,965 | (3,738,232) |
| Total operating expenses | 24,408,831 | 157,388,148 | 147,937,753 | 154,809,412 |
| Other operating income | 2,077,500 | 1,072,453 | ||
| Income from operations | 8,023,359 | 51,734,613 | 31,758,311 | 42,451,073 |
| Other income (loss): | ||||
| Share of net loss of equity method investments | (1,369,283) | (8,829,140) | (2,196,750) | |
| Interest income | 554,080 | 3,572,711 | 4,136,454 | 4,770,024 |
| Foreign currency exchange losses, net | (233,486) | (1,505,518) | (1,067,149) | (49,200) |
| Total other income (loss), net | (1,048,689) | (6,761,947) | 872,555 | 4,720,824 |
| Earnings before income taxes | 6,974,670 | 44,972,666 | 32,630,866 | 47,171,897 |
| Income tax expense | 2,934,473 | 18,921,479 | 9,575,146 | 19,895,462 |
| Net income | 4,040,197 | 26,051,187 | 23,055,720 | 27,276,435 |
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustment, net of nil income taxes | 310,570 | 2,002,553 | (30,753) | (766,783) |
| Comprehensive income | $ 4,350,767 | ¥ 28,053,740 | ¥ 23,024,967 | ¥ 26,509,652 |
| Basic earnings per common share (in CNY and dollars per share) | (per share) | $ 0.09 | ¥ 0.57 | ¥ 0.49 | ¥ 0.59 |
| Diluted earnings per common share (in CNY and dollars per share) | (per share) | $ 0.09 | ¥ 0.57 | ¥ 0.49 | ¥ 0.59 |
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|